Dawn C. Buse, PhD
Advertisement
Articles by Dawn C. Buse, PhD
Reducing the frequency of migraine is only 1 step in the process of optimizing management and addressing the disease's impact on patients’ lives.
Advertisement
Latest Updated Articles
Patient Selection of Novel Therapies for Migraine TreatmentPublished: October 28th 2020 | Updated:
Unmet Needs in the Management of MigrainePublished: October 28th 2020 | Updated:
Behavioral and Lifestyle Strategies for Migraine ManagementPublished: October 28th 2020 | Updated:
Acute Treatment of Migraine: Traditional TherapiesPublished: October 28th 2020 | Updated:
Role of Neuromodulation for Acute Treatment of MigrainePublished: October 28th 2020 | Updated:
Evolution of Acute Treatment of MigrainePublished: October 28th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis
2
FDA Clears Pivotal Phase 3 PREVAiLS Study of Pridopidine in Early, Rapidly Progressive ALS
3
Beyond Dravet and LGS: Elizabeth Thiele, MD, PhD, on New Data for Epidiolex in DEEs
4
Survey identifies Fever-Related Seizure Reduction as Key Feature of CDKL5 Deficiency Disorder
5
